secwatch.observer — SEC 8-K summary
======================================

Issuer:     MUSTANG BIO, INC. (MBIO)
CIK:        0001680048
Form:       8-K
Filed at:   2025-01-10T23:59:59+00:00
Accession:  0001104659-25-002599
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Mustang Bio stockholders authorize issuance of up to 34.8M shares underlying warrants
--------------------------------------------------------------------------------

- Stockholders representing ~57% voting power executed written consent approving warrant share issuance.
- Up to 34,767,934 shares of common stock may be issued under warrants to an institutional investor and H.C. Wainwright.
- Issuance complies with Nasdaq Listing Rule 5635(d) for transactions exceeding 20% of outstanding shares.
- Consent includes 6,552,781 common shares and 250,000 Class A Preferred shares (each with 285 votes).
- Previously disclosed Inducement Letter (Oct 24, 2024) and Engagement Letter (Oct 23, 2024) are the basis.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1680048/000110465925002599/0001104659-25-002599-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1680048/000110465925002599/tm252981d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-002599

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer